Market Tracker

02/24 5:16pm ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

0.6943
Delayed Data
As of Feb 24
 +0.004 / +0.58%
Today’s Change
0.51
Today|||52-Week Range
4.90
+6.96%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close0.69
Today’s open0.70
Day’s range0.66 - 0.70
Volume895,584
Average volume (3 months)1,760,399
Market cap$29.1M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+27.21%
Earnings growth (this year)-55.03%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales51.91
Price/Book0.70

Competitors

 Today’s
change
Today’s
% change
PPHMPPeregrine Pharmaceut...-0.30-1.60%
EYEGEyeGate Pharmaceutic...+0.04+1.42%
NVGNNovogen Ltd+0.02+1.18%
MSTXMast Therapeutics In...-0.00-2.52%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMarch 28, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$3.2M
Annual profit (last year)-$35.2M
Net profit margin-1,105.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Craig Thompson
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts